204 related articles for article (PubMed ID: 16409557)
21. Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.
Xu Y; Ahn JH; Cheng M; apRhys CM; Chiou CJ; Zong J; Matunis MJ; Hayward GS
J Virol; 2001 Nov; 75(22):10683-95. PubMed ID: 11602710
[TBL] [Abstract][Full Text] [Related]
22. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
23. Intranuclear rodlets in the substantia nigra: interactions with marinesco bodies, ubiquitin, and promyelocytic leukemia protein.
Woulfe J; Gray D; Prichett-Pejic W; Munoz DG; Chretien M
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1200-7. PubMed ID: 15581187
[TBL] [Abstract][Full Text] [Related]
24. Hornerin deposits in neuronal intranuclear inclusion disease: direct identification of proteins with compositionally biased regions in inclusions.
Park H; Yamanaka T; Toyama Y; Fujita A; Doi H; Nirasawa T; Murayama S; Matsumoto N; Shimogori T; Ikegawa M; Haltia MJ; Nukina N
Acta Neuropathol Commun; 2022 Mar; 10(1):28. PubMed ID: 35246273
[TBL] [Abstract][Full Text] [Related]
25. SUMO-1 promotes association of SNURF (RNF4) with PML nuclear bodies.
Häkli M; Karvonen U; Jänne OA; Palvimo JJ
Exp Cell Res; 2005 Mar; 304(1):224-33. PubMed ID: 15707587
[TBL] [Abstract][Full Text] [Related]
26. The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1.
Colombo R; Boggio R; Seiser C; Draetta GF; Chiocca S
EMBO Rep; 2002 Nov; 3(11):1062-8. PubMed ID: 12393750
[TBL] [Abstract][Full Text] [Related]
27. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.
Ohbayashi N; Kawakami S; Muromoto R; Togi S; Ikeda O; Kamitani S; Sekine Y; Honjoh T; Matsuda T
Biochem Biophys Res Commun; 2008 Jul; 371(4):823-8. PubMed ID: 18474224
[TBL] [Abstract][Full Text] [Related]
28. Ataxin 1 and ataxin 3 in neuronal intranuclear inclusion disease.
Lieberman AP; Trojanowski JQ; Leonard DG; Chen KL; Barnett JL; Leverenz JB; Bird TD; Robitaille Y; Malandrini A; Fischbeck KH
Ann Neurol; 1999 Aug; 46(2):271-3. PubMed ID: 10443897
[TBL] [Abstract][Full Text] [Related]
29. Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease.
Sone J; Tanaka F; Koike H; Inukai A; Katsuno M; Yoshida M; Watanabe H; Sobue G
Neurology; 2011 Apr; 76(16):1372-6. PubMed ID: 21411744
[TBL] [Abstract][Full Text] [Related]
30. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.
Lee HR; Kim DJ; Lee JM; Choi CY; Ahn BY; Hayward GS; Ahn JH
J Virol; 2004 Jun; 78(12):6527-42. PubMed ID: 15163746
[TBL] [Abstract][Full Text] [Related]
31. Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions.
Seilhean D; Takahashi J; El Hachimi KH; Fujigasaki H; Lebre AS; Biancalana V; Dürr A; Salachas F; Hogenhuis J; de Thé H; Hauw JJ; Meininger V; Brice A; Duyckaerts C
Acta Neuropathol; 2004 Jul; 108(1):81-7. PubMed ID: 15114487
[TBL] [Abstract][Full Text] [Related]
32. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.
Sone J; Mori K; Inagaki T; Katsumata R; Takagi S; Yokoi S; Araki K; Kato T; Nakamura T; Koike H; Takashima H; Hashiguchi A; Kohno Y; Kurashige T; Kuriyama M; Takiyama Y; Tsuchiya M; Kitagawa N; Kawamoto M; Yoshimura H; Suto Y; Nakayasu H; Uehara N; Sugiyama H; Takahashi M; Kokubun N; Konno T; Katsuno M; Tanaka F; Iwasaki Y; Yoshida M; Sobue G
Brain; 2016 Dec; 139(Pt 12):3170-3186. PubMed ID: 27797808
[TBL] [Abstract][Full Text] [Related]
34. Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.
Mosaheb S; Thorpe JR; Hashemzadeh-Bonehi L; Bigio EH; Gearing M; Cairns NJ
Acta Neuropathol; 2005 Oct; 110(4):360-8. PubMed ID: 16025283
[TBL] [Abstract][Full Text] [Related]
35. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
Chelbi-Alix MK; de Thé H
Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
[TBL] [Abstract][Full Text] [Related]
36. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
Bernardi R; Pandolfi PP
Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
[TBL] [Abstract][Full Text] [Related]
37. PML Nuclear Bodies Are Altered in Adult-Onset Neuronal Intranuclear Hyaline Inclusion Disease.
Nakano Y; Takahashi-Fujigasaki J; Sengoku R; Kanemaru K; Arai T; Kanda T; Murayama S
J Neuropathol Exp Neurol; 2017 Jul; 76(7):585-594. PubMed ID: 28863453
[TBL] [Abstract][Full Text] [Related]
38. Neuronal Intranuclear Inclusion Disease presenting as juvenile Parkinsonism.
Wiltshire KM; Dunham C; Reid S; Auer RN; Suchowersky O
Can J Neurol Sci; 2010 Mar; 37(2):213-8. PubMed ID: 20437931
[TBL] [Abstract][Full Text] [Related]
39. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation.
Morton AJ; Lagan MA; Skepper JN; Dunnett SB
J Neurocytol; 2000 Sep; 29(9):679-702. PubMed ID: 11353291
[TBL] [Abstract][Full Text] [Related]
40. Something about SUMO inhibits transcription.
Gill G
Curr Opin Genet Dev; 2005 Oct; 15(5):536-41. PubMed ID: 16095902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
